HACCP Inspection Availability To All Manufacturers Considered By FDA
This article was originally published in The Gray Sheet
Broad applicability of the Hazard Analysis and Critical Control Points (HACCP) inspection approach to the device industry is getting a second look by FDA due to the numerous inquiries it has received from manufacturers on the topic.
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.